Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia

<div>Comparison of EGIL criteria for BAL and the 2008 WHO criteria for MPAL. BAL, biphenotypic acute leukemia; EGIL, European Group for the Immunological Characterization of Leukemias; MPAL, mixed phenotype acute leukemia.</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Biphenotypic Acute Leukemia versus Myeloid Antigen-Positive ALL: Clinical Relevance of WHO Criteria for Mixed Phenotype Acute Leukemia 